A. V. Hoffbrand

13.1k citations
272 papers · 10.2k · h-index 56

Impact in

  • Genetics top 0.05%
    • Hemoglobinopathies and Related Disorders
    • Chronic Lymphocytic Leukemia Research
  • Hematology top 0.1%
    • Iron Metabolism and Disorders
    • Hematopoietic Stem Cell Transplantation
    • Acute Myeloid Leukemia Research

Papers in

  • Hematology 117
    • Iron Metabolism and Disorders 40
    • Hematopoietic Stem Cell Transplantation 39
    • Acute Myeloid Leukemia Research 33
  • Genetics 108
    • Chronic Lymphocytic Leukemia Research 52
    • Hemoglobinopathies and Related Disorders 47
Co-authors
B. Wonke (30 shared papers)K. Ganeshaguru (32 shared papers)H. G. Prentice (31 shared papers)George Janossy (21 shared papers)R. Gitendra Wickremasinghe (20 shared papers)Malcolm K. Brenner (22 shared papers)F. N. Al‐Refaie (12 shared papers)George J. Kontoghiorghes (7 shared papers)
Journals
British Journal of Haematology (50 papers)Blood (42 papers)Leukemia Research (20 papers)The Lancet (14 papers)Journal of Clinical Pathology (9 papers)
Partner nations
United KingdomUnited StatesGermany

In The Last Decade

A. V. Hoffbrand

269 papers receiving 9.5k citations

Peers

A. V. Hoffbrand
Comparison fields: 5 of 147
  • Genetics 3.9k
  • Hematology 4.2k
  • Immunology 2.3k
  • Pathology and Forensic Medicine 855
  • Oncology 1.3k
Replace Edo Vellenga with:
Edo Vellenga Netherlands
Robert W. Colman United States
Richard J. Jones United States
Karl G. Blume United States
Magnus Björkholm Sweden
Jordan U. Gutterman United States
James L.M. Ferrara United States
Guido Tricot United States
Robert A. Brodsky United States
Tomoki Naoe Japan
A. V. Hoffbrand relative to Edo Vellenga Netherlands Edo Vellenga's profile →
Citations per field
00.5×1.7×
Edo Vellenga · 1×
Citations per year

Countries citing papers authored by A. V. Hoffbrand

Since Specialization
Citations

This map shows the geographic impact of A. V. Hoffbrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. V. Hoffbrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. V. Hoffbrand more than expected).

Fields of papers citing papers by A. V. Hoffbrand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. V. Hoffbrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. V. Hoffbrand. The network helps show where A. V. Hoffbrand may publish in the future.

Co-authors

The 25 scholars most cited alongside A. V. Hoffbrand, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with A. V. Hoffbrand Line = papers co-authored together A. V. Hoffbrand links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 272 papers — load more, or switch the sort, to bring in the rest.

#Work
1
DEPLETION OF T LYMPHOCYTES IN DONOR MARROW PREVENTS SIGNIFICANT GRAFT-VERSUS-HOST DISEASE IN MATCHED ALLOGENEIC LEUKAEMIC MARROW TRANSPLANT RECIPIENTS
The Lancet ·H. G. Prentice, George Janossy, L. Price-Jones, L K Trejdosiewicz, Dilip Panjwani, Stelios Graphakos, Kamal Ivory, Hilary Blacklock, M. J. M. L. Gilmore, N Tidman, D. Skeggs, Sarah E. Ball, J. Patterson, A. V. Hoffbrand
1984277
2
Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro
British Journal of Haematology ·Panayiotis Panayiotidis, Dylan T. Jones, K. Ganeshaguru, Letizia Foroni, A. V. Hoffbrand
1996255
3
TUMOUR NECROSIS FACTOR AS AN AUTOCRINE TUMOUR GROWTH FACTOR FOR CHRONIC B-CELL MALIGNANCIES
The Lancet ·F. T. Cordingley, A. V. Hoffbrand, HE Heslop, Martin Turner, A.M. Bianchi, Joyce E. Reittie, Annapurna Vyakarnam, Anthony Meager, Malcolm K. Brenner
1988241
4
Interferon gamma inhibits apoptotic cell death in B cell chronic lymphocytic leukemia.
The Journal of Experimental Medicine ·Michael Buschle, Dario Campana, Simon R. Carding, Carlos Richard, A. V. Hoffbrand, Malcolm K. Brenner
1993212
5
Hepatic iron concentration combined with long‐term monitoring of serum ferritin to predict complications of iron overload in thalassaemia major
British Journal of Haematology ·Paul Telfer, E. Prestcott, Sally Holden, John M. Walker, A. V. Hoffbrand, B. Wonke
2000198
6
Role of deferiprone in chelation therapy for transfusional iron overload
Blood ·A. V. Hoffbrand, Alan R. Cohen, Chaim Hershko
2003193
7
Hepatic iron stores and markers of iron overload in alcoholics and patients with idiopathic hemochromatosis
Digestive Diseases and Sciences ·Roger W. Chapman, Marsha Y. Morgan, M Laulicht, A. V. Hoffbrand, Sheila Sherlock
1982172
8
USE OF ANTI-T-CELL MONOCLONAL ANTIBODY OKT3 TO PREVENT ACUTE GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE LEUKAEMIA
The Lancet ·H. G. Prentice, George Janossy, D. Skeggs, Hilary Blacklock, K. F. Bradstock, Gideon Goldstein, A. V. Hoffbrand
1982172
9
IMMUNE DONORS CAN PROTECT MARROW-TRANSPLANT RECIPIENTS FROM SEVERE CYTOMEGALOVIRUS INFECTIONS
The Lancet ·Jean‐Jacques Grob, H. G. Prentice, A. V. Hoffbrand, Teresa Tate, J. E. Grundy, Paul Griffiths, Melody Hughes, J. Z. Wimperis, Malcolm K. Brenner
1987167
10
The Human Thymic Microenvironment: An Immunohistologic Study
The Journal of Immunology ·George Janossy, JA Thomas, FJ Bollum, S Grnager, Giovanni Pizzolo, KF Bradstock, Lawson L. S. Wong, A J McMichael, K. Ganeshaguru, A. V. Hoffbrand
1980165
11
Long-Term Trial of Deferiprone in 51 Transfusion-Dependent Iron Overloaded Patients
Blood ·A. V. Hoffbrand, F. N. Al‐Refaie, Bernard A. Davis, Noppadol Siritanakatkul, B. F. A. Jackson, John Cochrane, Eva Prescott, B. Wonke
1998163
12
Effective chelation of iron in beta thalassaemia with the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one.
BMJ ·George J. Kontoghiorghes, M. A. Aldouri, A. V. Hoffbrand, Joseph Barr, B. Wonke, T Kourouclaris, L Sheppard
1987156
13
1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE, AN ORALLY ACTIVE CHELATOR FOR TREATMENT OF IRON OVERLOAD
The Lancet ·GeorgeJ. Kontoghiorghes, L Sheppard, M. A. Aldouri, A. V. Hoffbrand
1987148
14
Results of long‐term deferiprone (L1) therapy: a report by the International Study Group on Oral Iron Chelators
British Journal of Haematology ·F. N. Al‐Refaie, C Hershko, A. V. Hoffbrand, Mehrnoush Kosaryan, Nancy F. Olivieri, Petrign TÖndury, B. Wonke
1995145
15
Progress in the Diagnosis and Management of Aspergillosis in Bone Marrow Transplantation: 13 Years' Experience
Clinical Infectious Diseases ·Paul McWhinney, C Kibbler, M. D. Hamon, Owen Smith, (unknown), L. A. Berger, R.K. Walesby, A. V. Hoffbrand, H. G. Prentice
1993140
16
Terminal Transferase Enzyme Assay and Immunological Membrane Markers in the Diagnosis of Leukaemia: a Multiparameter Analysis of 300 Cases
British Journal of Haematology ·George Janossy, A. V. Hoffbrand, Melvyn F. Greaves, K. Ganeshaguru, Carol Pain, Kenneth F. Bradstock, H. G. Prentice, H. E. M. Kay, T. Andrew Lister
1980133
17
Efficacy and possible adverse effects of the oral iron chelator 1,2- dimethyl-3-hydroxypyrid-4-one (L1) in thalassemia major [see comments]
Blood ·FN al-Refaie, B. Wonke, A. V. Hoffbrand, DG Wickens, P. Nortey, Kontoghiorghes Gj
1992131
18
Interleukin‐4 inhibits apoptotic cell death and loss of the bcl‐2 protein in B‐chronic lymphocytic leukaemia cells in vitro
British Journal of Haematology ·Panayiotis Panayiotidis, K. Ganeshaguru, Shireen A. B. Jabbar, A. V. Hoffbrand
1993127
19
TRANSFER OF A FUNCTIONING HUMORAL IMMUNE SYSTEM IN TRANSPLANTATION OF T-LYMPHOCYTE-DEPLETED BONE MARROW
The Lancet ·J. Z. Wimperis, H. G. Prentice, Peter Karayiannis, Malcolm K. Brenner, Joyce E. Reittie, Paul Griffiths, A. V. Hoffbrand
1986127
20
KETOCONAZOLE VERSUS NYSTATIN PLUS AMPHOTERICIN B FOR FUNGAL PROPHYLAXIS IN SEVERELY IMMUNOCOMPROMISED PATIENTS
The Lancet ·Ian Hann, Robert Corringham, M.G.L. Keaney, Paul Noone, J. T. Fox, Melvyn Szawatkowski, H. G. Prentice, Hilary Blacklock, Muriel S. Shannon, E. Gascoigne, E. Boesen, A. V. Hoffbrand
1982126

About A. V. Hoffbrand

A. V. Hoffbrand is a scholar working on Hematology, Genetics, Molecular Biology, Immunology and Public Health, Environmental and Occupational Health, having authored 272 papers that have together received 10.2k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (52 papers), Hemoglobinopathies and Related Disorders (47 papers), Acute Lymphoblastic Leukemia research (41 papers), Iron Metabolism and Disorders (40 papers), Hematopoietic Stem Cell Transplantation (39 papers), Biochemical and Molecular Research (33 papers), Acute Myeloid Leukemia Research (33 papers) and Folate and B Vitamins Research (21 papers). The work is most often cited by research in Genetics (3.9k citations), Hematology (4.2k citations), Immunology (2.3k citations), Pathology and Forensic Medicine (855 citations) and Oncology (1.3k citations). A. V. Hoffbrand has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include B. Wonke, K. Ganeshaguru, H. G. Prentice, George Janossy, R. Gitendra Wickremasinghe, Malcolm K. Brenner, F. N. Al‐Refaie, George J. Kontoghiorghes, L Sheppard and H. G. Prentice. Their work appears in journals such as British Journal of Haematology, Blood, Leukemia Research, The Lancet and Journal of Clinical Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Edo VellengaBreakdown of academic impact, for papers by Robert W. ColmanBreakdown of academic impact, for papers by Richard J. JonesBreakdown of academic impact, for papers by Karl G. BlumeBreakdown of academic impact, for papers by Magnus BjörkholmBreakdown of academic impact, for papers by Jordan U. GuttermanBreakdown of academic impact, for papers by James L.M. FerraraBreakdown of academic impact, for papers by Guido TricotBreakdown of academic impact, for papers by Robert A. BrodskyBreakdown of academic impact, for papers by Tomoki Naoe